duration of response

13 papers and 1 presentation; 14 titles.

Back to keywords

Conference ×	Year ×	Title ×	Authors	Extras	Pages
PharmaSUG	2026	Oncology Solid Tumor Subcutaneous vs Intravenous Late-stage Study Analysis	Sumanjali Mangalarapu, Chuqing Chen, Anilkumar Anksapur	source	11
PharmaSUG	2025	Efficacy Endpoints Related to CNS in Oncology Studies within ADaM	Lihui Deng, Kylie Fan	source	6
PharmaSUG	2025	Roadmap to Efficacy Analysis for Early Phase Oncology studies	Dhruv Bansal, Christiana Hawn, Chris Kelly	source	23
PHUSE US	2025	Unravelling the Complexity: Efficacy Datasets in Oncology Basket Trials Across Multiple Diseases	Venkatesh Burla, Manasa Ravi	source presentation source	7
PharmaSUG	2024	ADaM Design for Prostate Cancer Efficacy Endpoints Based on PCWG3	Lihui Deng, Kylie Fan, Jia Li	source	10
PharmaSUG	2023	Programmer-s Perspective: Step into Awareness Regarding Clinical Trial Deliverables and Their Impact	Lyma Faroz, Jinit Mistry	source	10
PharmaSUG	2022	Derivation of Efficacy Endpoints by iRECIST Criteria: A Practical Approach	Ilya Krivelevich, Lei Gao, Richard Kennan	source	9
PHUSE EU	2021	How Has the Immunotherapy Era Changed Response Criteria? [presentation]	Anna Amosova	source video	30
PHUSE US	2020	Efficacy ADaMs in Oncology - Step by Step (Dataset by Dataset)	Ilya Krivelevich, Ran Xie	source presentation source	8
PharmaSUG	2019	Fine-tuning your swimmer plot: another example from oncology	Steve Almond	source	25
PHUSE US	2019	Efficacy Endpoint Visualization of Investigational Products for Cancer Patients Using R Shiny	Beverly Martinez, Mukul K Mittal	source presentation source	12
PharmaSUG	2012	Calculating time-to-event parameters using a single DATA step and a RETAIN statement	Andrew L Hulme	source	7
PHUSE EU	2008	RECIST Temptation	Paul Jenkins	source	8
MWSUG	2008	Creating Macros for Survival Data in Oncology Study	Jagannath Ghosh		8

Back to keywords